UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Solitary Fibrous Tumor – Less Common Neoplasms of the Pleural Cavity

Annals of Thoracic and Cardiovascular Surgery, 2017, Vol.23(1), pp.12-18

2017

Link zum Volltext

Verfügbarkeit prüfen

Outcomes for Patients after Resection of Pulmonary Metastases from Clear Cell Renal Cell Carcinoma: 18 Years of Experience

Urologia internationalis, 2019-10, Vol.103 (3), p.297-302

2019

Link zum Volltext

Verfügbarkeit prüfen

Dual-Phase Dual-Energy CT in Patients Treated with Erlotinib for Advanced Non-Small Cell Lung Cancer: Possible Benefits of Iodine Quantification in Response Assessment

European radiology, 2016-08, Vol.26 (8), p.2828-2836

2016

Link zum Volltext

Verfügbarkeit prüfen

The Use of CT Pattern in Differentiating Non-invasive, Minimally Invasive and Invasive Variants of Lung Adenocarcinoma

Anticancer research, 2021-09, Vol.41 (9), p.4479-4482

2021

Link zum Volltext

Verfügbarkeit prüfen

P1.04-012 Single Center Experience with Nivolumab Administration in NSCLC Patients from EAP Program: Topic: Pulmonology

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S602-S603

2017

Link zum Volltext

Verfügbarkeit prüfen

P1.04-012 Single Center Experience with Nivolumab Administration in NSCLC Patients from EAP Program

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S602-S603

2017

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Role for CYFRA 21-1 in Patients With Advanced-stage NSCLC Treated With Bevacizumab Plus Chemotherapy

Anticancer research, 2021-04, Vol.41 (4), p.2053-2058

2021

Link zum Volltext

Verfügbarkeit prüfen

P1.04-013 Diagnostics and Treatment of ALK-Positive NSCLC Patients - A Single Center Experience: Topic: Pulmonology

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S603-S603

2017

Link zum Volltext

Verfügbarkeit prüfen

P1.04-013 Diagnostics and Treatment of ALK-Positive NSCLC Patients - A Single Center Experience

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S603

2017

Link zum Volltext

Verfügbarkeit prüfen

Laboratory Parameters are Possible Prognostic Markers in Patients with Advanced-stage NSCLC Treated with Bevacizumab plus Chemotherapy

Journal of Cancer, 2021-01, Vol.12 (19), p.5753-5759

2021

Link zum Volltext

Verfügbarkeit prüfen

Lung Cancer in Non-smokers in Czech Republic: Data from LUCAS Lung Cancer Clinical Registry

Anticancer research, 2021-11, Vol.41 (11), p.5549-5556

2021

Link zum Volltext

Verfügbarkeit prüfen

Thyroid transcription factor 1 and p63 expression is associated with survival outcome in patients with non‑small cell lung cancer treated with erlotinib

Oncology letters, 2020-08, Vol.20 (2), p.1376-1382

2020

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Significance of ERCC1, RRM1 and BRCA1 in Surgically-treated Patients with Non-small Cell Lung Cancer

Anticancer research, 2012-11, Vol.32 (11), p.5003-5010

2012

Link zum Volltext

Verfügbarkeit prüfen

Aggressive pulmonary adenocarcinoma with new FGFR translocation and cMET mutation not responsive to crizotinib and nintedanib treatment: a case report

Translational cancer research, 2020-03, Vol.9 (3), p.2082-2088

2020

Link zum Volltext

Verfügbarkeit prüfen

10th Anniversary of the European Association for Predictive, Preventive and Personalised (3P) Medicine - EPMA World Congress Supplement 2020

The EPMA journal, 2020, Vol.11 (Suppl 1), p.1-133

2020

Link zum Volltext

Verfügbarkeit prüfen

Retreatment with erlotinib of a patient with metastatic NSCLC harboring EGFR mutation: a case report

Tumori, 2014-05, Vol.100 (3), p.e70-e73

2014

Link zum Volltext

Verfügbarkeit prüfen

Retreatment with erlotinib of a patient with metastatic NSCLC harboring EGFR mutation: a case report

Tumori, 2014-05, Vol.100 (3), p.e70-e73

2014

Link zum Volltext

Verfügbarkeit prüfen

Monotherapy with pembrolizumab in the first-line treatment of non-small cell lung cancer with a high expression of PD-L1 ≥ 50

Onkologie (Olomouc), 2020-06, Vol.14 (Suppl.D), p.78-81

2020

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic and therapeutic guidelines for stage III non-small-cell lung cancer

Onkologie (Olomouc), 2016-03, Vol.10 (1), p.11-14

Krákorová, Gabriela

2016

Link zum Volltext

Verfügbarkeit prüfen

Relevance of ERCC1, RRM1 and BRCA1 in surgically treated non-small cell lung cancer patients

The EPMA journal, 2014-02, Vol.5 (Suppl 1), p.1-A27, Article A27

2014

Link zum Volltext

Verfügbarkeit prüfen

Aggressive pulmonary adenocarcinoma with new FGFR translocation and cMET mutation not responsive to crizotinib and nintedanib treatment: a case report

Translational cancer research, 2020, Vol.9 (3), p.2082-2088

2020

Link zum Volltext

Verfügbarkeit prüfen

D3-01: Genotyping single-nucleotide polymorphisms(SNP) in ERCC1, XPD, XRCC1, XRCC3 and MDR1 and CCND1 genes for response and toxicity prediction in chemotherapy of non small cell lung cancer (NSCLC)

Journal of thoracic oncology, 2007-08, Vol.2 (8), p.S396-S397

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(21)
Berichte
(1)

Sprache

Englisch
(22)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Lung Cancer
(8)
Oncology
(8)
Female
(6)
Humans
(6)
Aged
(5)
Male
(5)
Lung Neoplasms - Pathology
(4)
Middle Aged
(4)
Nsclc
(4)
Patients
(4)
Treatment Outcome
(4)
Tumors
(4)
Antineoplastic Agents - Therapeutic Use
(3)
Cancer Therapies
(3)
Chemotherapy
(3)
Lung Neoplasms - Drug Therapy
(3)
Mutation
(3)
Neoplasm Staging
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Solitary Fibrous Tumor – Less Common Neoplasms of the Pleural Cavity

Outcomes for Patients after Resection of Pulmonary Metastases from Clear Cell Renal Cell Carcinoma: 18 Years of Experience

Dual-Phase Dual-Energy CT in Patients Treated with Erlotinib for Advanced Non-Small Cell Lung Cancer: Possible Benefits of Iodine Quantification in Response Assessment

The Use of CT Pattern in Differentiating Non-invasive, Minimally Invasive and Invasive Variants of Lung Adenocarcinoma

P1.04-012 Single Center Experience with Nivolumab Administration in NSCLC Patients from EAP Program: Topic: Pulmonology

P1.04-012 Single Center Experience with Nivolumab Administration in NSCLC Patients from EAP Program

Prognostic Role for CYFRA 21-1 in Patients With Advanced-stage NSCLC Treated With Bevacizumab Plus Chemotherapy

P1.04-013 Diagnostics and Treatment of ALK-Positive NSCLC Patients - A Single Center Experience: Topic: Pulmonology

P1.04-013 Diagnostics and Treatment of ALK-Positive NSCLC Patients - A Single Center Experience

Laboratory Parameters are Possible Prognostic Markers in Patients with Advanced-stage NSCLC Treated with Bevacizumab plus Chemotherapy

Lung Cancer in Non-smokers in Czech Republic: Data from LUCAS Lung Cancer Clinical Registry

Thyroid transcription factor 1 and p63 expression is associated with survival outcome in patients with non‑small cell lung cancer treated with erlotinib

Prognostic Significance of ERCC1, RRM1 and BRCA1 in Surgically-treated Patients with Non-small Cell Lung Cancer

Aggressive pulmonary adenocarcinoma with new FGFR translocation and cMET mutation not responsive to crizotinib and nintedanib treatment: a case report

10th Anniversary of the European Association for Predictive, Preventive and Personalised (3P) Medicine - EPMA World Congress Supplement 2020

Retreatment with erlotinib of a patient with metastatic NSCLC harboring EGFR mutation: a case report

Retreatment with erlotinib of a patient with metastatic NSCLC harboring EGFR mutation: a case report

Monotherapy with pembrolizumab in the first-line treatment of non-small cell lung cancer with a high expression of PD-L1 ≥ 50

Diagnostic and therapeutic guidelines for stage III non-small-cell lung cancer

Relevance of ERCC1, RRM1 and BRCA1 in surgically treated non-small cell lung cancer patients

Aggressive pulmonary adenocarcinoma with new FGFR translocation and cMET mutation not responsive to crizotinib and nintedanib treatment: a case report

D3-01: Genotyping single-nucleotide polymorphisms(SNP) in ERCC1, XPD, XRCC1, XRCC3 and MDR1 and CCND1 genes for response and toxicity prediction in chemotherapy of non small cell lung cancer (NSCLC)

Suchergebnisse filtern